drug adverse effect(s)
Jump to navigation
Jump to search
Etiology
risk factors
- age > 85 years
- low BMI
- >= 6 chronic diagnoses
- estimated creatinine clearance of < 50 mL/min
- >= 9 medications
- >= 12 medication doses/day
- prior adverse drug effect[1]
- hospital discharge of older adults (20%)[2]
- 1/3 considered preventable
- 17% involve drugs on Beer's list[2]
Epidemiology
- elderly at 2-fold risk, 7-fold risk of hospitalization
- 4 medications account for 2/3 of hospitalizations[3]
- warfarin (33%)
- insulin (14%)
- antiplatelet agents (13%)
- oral hypoglycemic agents (11%)
- most commonly implicated drugs leading to emergency department visits by age[4]
- > 64 years: anticoagulants, clopidogrel, insulin
- 45-64 years: insulin & warfarin
- 25-44 years: alprozolam & insulin
- 15-24 years: alprozolam & ibuprofen[4]
- low visual acuity & low health literacy increase risk for drug dosing errors & other unintentianal misuse of drugs[5]
Notes
More general terms
More specific terms
- adverse drug effects in the elderly
- antibiotic side effects in the elderly
- antibiotic-associated diarrhea (AAD)
- cannabinoid/cannabis hyperemesis syndrome
- common prescription drugs associated with insomnia
- differentiation syndrome
- diuretic resistance
- drug adverse effects of 5-alpha reductase inhibitors
- drug adverse effects of ACE inhibitors
- drug adverse effects of ADHD medications
- drug adverse effects of adrenergic receptor agonists
- drug adverse effects of alkylating agents
- drug adverse effects of alpha-1 adrenergic receptor antagonists
- drug adverse effects of alpha-adrenergic receptor agonists
- drug adverse effects of aminoglycosides
- drug adverse effects of analeptics
- drug adverse effects of androgens
- drug adverse effects of angiotensin II receptor antagonists
- drug adverse effects of antacid(s)
- drug adverse effects of anthracyclines
- drug adverse effects of anti-Alzheimer monoclonal antibody
- drug adverse effects of anti-bacterial agent(s)
- drug adverse effects of anti-hyperlipidemic agents
- drug adverse effects of antiarrhythmic agent, Group IA
- drug adverse effects of antiarrhythmic agent, Group IC
- drug adverse effects of antiarrhythmic agent, Group III
- drug adverse effects of anticonvulsants
- drug adverse effects of antidepressants
- drug adverse effects of antihypertensive agents
- drug adverse effects of antimalarials
- drug adverse effects of antiplatelet agents
- drug adverse effects of antipsychotic agents
- drug adverse effects of antiretroviral agents
- drug adverse effects of antiretroviral protease inhibitors
- drug adverse effects of antithrombotic agent(s)
- drug adverse effects of antithyroid agent(s)
- drug adverse effects of antitussive agent(s)
- drug adverse effects of aromatase inhibitors
- drug adverse effects of atypical antipsychotic agents
- drug adverse effects of benzodiazepines
- drug adverse effects of beta-1 adrenergic receptor antagonists
- drug adverse effects of beta-adrenergic receptor agonists
- drug adverse effects of beta-adrenergic receptor antagonists
- drug adverse effects of biologic immunosuppressive agents
- drug adverse effects of bisphosphonates
- drug adverse effects of calcineurin inhibitors
- drug adverse effects of calcium channel blockers
- drug adverse effects of calclium supplement(s)
- drug adverse effects of carbonic anhydrase inhibitor(s)
- drug adverse effects of cephalosporins
- drug adverse effects of checkpoint inhibitor(s)
- drug adverse effects of cholinesterase inhibitors
- drug adverse effects of contrast agents
- drug adverse effects of COX-2-specific inhibitors
- drug adverse effects of direct oral anticoagulants
- drug adverse effects of diuretics
- drug adverse effects of dopaminergic receptor agonists
- drug adverse effects of dopaminergic receptor antagonists
- drug adverse effects of EGF receptor inhibitors
- drug adverse effects of erythropoiesis-stimulating agents
- drug adverse effects of estrogens
- drug adverse effects of fibrates
- drug adverse effects of fluoroquinolones
- drug adverse effects of gabapentinoids
- drug adverse effects of ginsengs
- drug adverse effects of gliptins
- drug adverse effects of glitazones
- drug adverse effects of glucocorticoids
- drug adverse effects of glycoprotein IIb/IIIa inhibitor
- drug adverse effects of GnRH agonists
- drug adverse effects of H1 receptor antagonists
- drug adverse effects of H2-receptor antagonists
- drug adverse effects of HMG CoA reductase inhibitors
- drug adverse effects of hormonal contraception
- drug adverse effects of hypoglycemic agents
- drug adverse effects of immunosuppressive agents
- drug adverse effects of incretin mimetics
- drug adverse effects of janus kinase inhibitors
- drug adverse effects of leukotriene receptor antagonists
- drug adverse effects of lipophilic statins
- drug adverse effects of LMW heparin
- drug adverse effects of long-acting beta-adrenergic receptor agonists
- drug adverse effects of loop diuretics
- drug adverse effects of macrolide(s)
- drug adverse effects of MAO inhibitors
- drug adverse effects of neuraminidase inhibitor(s)
- drug adverse effects of nitrites
- drug adverse effects of nitrofurantoin
- drug adverse effects of non-nucleoside reverse transcriptase inhibitors (NNRTI)
- drug adverse effects of NSAIDs
- drug adverse effects of opiates
- drug adverse effects of oral glucosuric agent; SGLT-2 inhibitor; flozin
- drug adverse effects of P2Y12 receptor inhibitor(s)
- drug adverse effects of parasympatholytics
- drug adverse effects of PCSK9 inhibitor(s)
- drug adverse effects of pharmaceutical monoclonal antibodies
- drug adverse effects of phosphodiesterase-5-inhibitors
- drug adverse effects of platinum-based chemotherapy
- drug adverse effects of proton pump inhibitors (PPI)
- drug adverse effects of psychotropic agents
- drug adverse effects of renin-angiotensin-aldosterone system inhibitors (RAAS inhibitors)
- drug adverse effects of sedatives
- drug adverse effects of SSRIs
- drug adverse effects of sulfonamides
- drug adverse effects of sulfonylureas
- drug adverse effects of sympathomimetic(s)
- drug adverse effects of thiazide diuretics
- drug adverse effects of thiazolidinediones
- drug adverse effects of thiopurines
- drug adverse effects of TNF-alpha inhibitors
- drug adverse effects of topical glucocorticoids
- drug adverse effects of tricyclic antidepressants
- drug adverse effects of triptan(s)
- drug adverse effects of tumor necrosis factor (TNF) inhibitors
- drug adverse effects of tyrosine kinase inhibitor(s)
- drug dependence
- drug-induced glomerulonephritis (GN)
- drug-seeking behavior
- drugs associated with hyponatremia
- drugs associated with myopathy
- drugs associated with weight gain
- drugs that increase vasopressin or enhance its action
- intoxication
- medications causing dysphagia
- opioid-induced constipation (OIC)
- pharmaceutical agents associated with confusion
- pharmaceutical agents associated with diarrhea
- pharmaceutical agents associated with headache
- pharmaceutical agents associated with myalgia
- pharmaceutical agents associated with seizures; drugs that lower seizure threshold
- pharmaceutical agents causing leg cramps
- substance abuse
Additional terms
- ↑ Cite error: Invalid
<ref>
tag; no text was provided for refs namedref3
- ↑ 2.0 2.1 Cite error: Invalid
<ref>
tag; no text was provided for refs namedref4
- ↑ Cite error: Invalid
<ref>
tag; no text was provided for refs namedref2
- ↑ 4.0 4.1 Cite error: Invalid
<ref>
tag; no text was provided for refs namedref6
- ↑ Cite error: Invalid
<ref>
tag; no text was provided for refs namedref5